LISATA THERAPEUTICS, INC. Unrecognized Tax Benefits, Increase Resulting from Acquisition
LISATA THERAPEUTICS, INC. (LSTA) reported Unrecognized Tax Benefits, Increase Resulting from Acquisition of $344.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition · last filed 2023-11-02
- LISATA THERAPEUTICS, INC. unrecognized tax benefits, increase resulting from acquisition for the quarter ending 2023-03-31 was $344.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Acquisition | Unrecognized Tax Benefits, Increase Resulting from Acquisition 3 month | Unrecognized Tax Benefits, Increase Resulting from Acquisition 12 month |
|---|---|---|---|
| 2023-03-31 | $344.00K 10-Q · filed 2023-08-14 | ||
| 2022-12-31 | $344.00K 10-Q · filed 2023-05-09 | ||
| 2022-09-15 | $344.00K 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |